Lena Tjeldhorn

About

Lena Tjeldhorn is a genetic researcher whose work has significantly advanced the molecular understanding of Marfan syndrome (MFS) and related type-1 fibrillinopathies. Her primary research focus lies in the genotype-phenotype correlation of the *FBN1* gene, which encodes fibrillin-1. Tjeldhorn’s major contributions include pioneering a rapid and efficient mutation detection strategy for the *FBN1* gene, a notoriously challenging task given its 8,600-base-pair coding region spanning 65 exons. By implementing automated sample preparation and direct sequencing as the primary diagnostic approach, she streamlined the identification of pathogenic variants, enabling earlier and more accurate genetic testing. Her most cited work, a 2007 study on 44 unrelated Norwegian MFS patients, systematically searched for correlations between *FBN1* genotype and the complete Ghent phenotype. This research is foundational for predictive genetic testing, offering the potential for prophylaxis and tailored clinical follow-up in affected individuals. With her top paper garnering 34 citations and a second highly influential study cited 20 times, Tjeldhorn’s work remains a key reference for clinicians and researchers seeking to link genetic findings with patient outcomes, ultimately improving prognostic accuracy in this monogenic disorder.

Research Focus

Key Achievements

Top Papers

1. 1
   Search for correlations between <i>FBN1</i> genotype and complete Ghent phenotype in 44 unrelated Norwegian patients with Marfan syndrome

   34 citations · 2007
2. 2
   Rapid and Efficient <i>FBN1</i> Mutation Detection Using Automated Sample Preparation and Direct Sequencing As the Primary Strategy

   20 citations · 2006

Key Collaborators

Contact & Links